Klair Jagpal Singh, Yang Ju Dong, Abdelmalek Manal F, Guy Cynthia D, Gill Ryan M, Yates Katherine, Unalp-Arida Aynur, Lavine Joel E, Clark Jeanne M, Diehl Anna Mae, Suzuki Ayako
Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.
Hepatology. 2016 Jul;64(1):85-91. doi: 10.1002/hep.28514. Epub 2016 Apr 5.
Postmenopausal women with nonalcoholic steatohepatitis are at an increased risk of hepatic fibrosis compared with premenopausal women. Whether duration of estrogen deficiency in postmenopausal state dictates an individual's fibrosis risk remains uninvestigated. We assessed the associations of age at menopause and time from menopause with fibrosis severity in postmenopausal women with nonalcoholic fatty liver disease. Data from 488 postmenopausal women with (1) histologic diagnosis of nonalcoholic fatty liver disease and (2) self-reported information on age at menopause were analyzed. The associations of premature menopause (age at menopause of <40 years) and time from menopause (age at study enrollment - age at menopause, years) with fibrosis severity (stage 0-4) were assessed using multiple ordinal logistic regression models with and without adjusting for clinical confounders. Among the participants (age at menopause 43.7 ± 8.6 years), women with premature menopause (29.3%) were younger at enrollment (P < 0.001) and used hormone replacement therapy more often (P < 0.003). After adjusting for age at enrollment, race, waist circumference standardized by body mass index, current smoking, current alcohol use, hypertension, diabetes/impaired fasting glucose, homeostatic model assessment of insulin resistance, and hormone replacement therapy, premature menopause was associated with an increased likelihood of having more severe fibrosis (adjusted cumulative odds ratio = 1.9, 95% confidence interval 1.3-2.7, P = 0.001), while time from menopause was directly associated with an increased likelihood of having more severe fibrosis (adjusted cumulative odds ratio for 5-year unit = 1.2, 95% confidence interval 1.1-1.3, P = 0.002).
Duration of estrogen deficiency in postmenopausal state confers fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. (Hepatology 2016;64:85-91).
与绝经前女性相比,患有非酒精性脂肪性肝炎的绝经后女性发生肝纤维化的风险更高。绝经后雌激素缺乏的持续时间是否决定个体的纤维化风险仍未得到研究。我们评估了绝经年龄和绝经时间与患有非酒精性脂肪性肝病的绝经后女性纤维化严重程度之间的关联。分析了488名绝经后女性的数据,这些女性满足以下条件:(1)经组织学诊断为非酒精性脂肪性肝病;(2)有关于绝经年龄的自我报告信息。使用多序贯逻辑回归模型评估过早绝经(绝经年龄<40岁)和绝经时间(研究入组年龄 - 绝经年龄,单位:年)与纤维化严重程度(0 - 4期)之间的关联,模型分为调整临床混杂因素和未调整临床混杂因素两种情况。在参与者中(绝经年龄43.7±8.6岁),过早绝经的女性(29.3%)入组时更年轻(P<0.001),且更常使用激素替代疗法(P<0.003)。在调整了入组年龄、种族、体重指数标准化的腰围、当前吸烟情况、当前饮酒情况、高血压、糖尿病/空腹血糖受损、胰岛素抵抗的稳态模型评估以及激素替代疗法后,过早绝经与更严重纤维化的可能性增加相关(调整后的累积比值比 = 1.9,95%置信区间1.3 - 2.7,P = 0.001),而绝经时间与更严重纤维化的可能性增加直接相关(每5年单位的调整累积比值比 = 1.2,95%置信区间1.1 - 1.3,P = 0.002)。
绝经后状态下雌激素缺乏的持续时间赋予了患有非酒精性脂肪性肝病的绝经后女性纤维化风险。(《肝脏病学》2016年;64卷:85 - 91页)